A detailed history of Tower Research Capital LLC (Trc) transactions in Volitionrx LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,526 shares of VNRX stock, worth $1,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,526
Previous 13,911 81.84%
Holding current value
$1,540
Previous $10,000 90.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.72 - $1.19 $8,197 - $13,548
-11,385 Reduced 81.84%
2,526 $1,000
Q4 2023

Feb 13, 2024

BUY
$0.55 - $0.88 $3,234 - $5,174
5,880 Added 73.22%
13,911 $10,000
Q3 2023

Nov 14, 2023

SELL
$0.69 - $1.53 $2,842 - $6,302
-4,119 Reduced 33.9%
8,031 $5,000
Q2 2023

Aug 14, 2023

BUY
$1.39 - $2.02 $8,205 - $11,924
5,903 Added 94.49%
12,150 $16,000
Q1 2023

May 09, 2023

BUY
$1.54 - $2.68 $1,961 - $3,414
1,274 Added 25.62%
6,247 $12,000
Q4 2022

Feb 10, 2023

SELL
$1.63 - $2.6 $17,416 - $27,781
-10,685 Reduced 68.24%
4,973 $12,000
Q3 2022

Nov 10, 2022

BUY
$1.57 - $2.38 $13,811 - $20,936
8,797 Added 128.22%
15,658 $21,000
Q2 2022

Aug 15, 2022

BUY
$1.96 - $3.05 $7,663 - $11,925
3,910 Added 132.5%
6,861 $14,000
Q1 2022

May 12, 2022

SELL
$2.41 - $3.24 $2,417 - $3,249
-1,003 Reduced 25.37%
2,951 $9,000
Q4 2021

Feb 14, 2022

BUY
$3.02 - $4.13 $11,639 - $15,917
3,854 Added 3854.0%
3,954 $12,000
Q3 2021

Nov 15, 2021

SELL
$2.98 - $3.48 $11,675 - $13,634
-3,918 Reduced 97.51%
100 $0
Q2 2021

Aug 16, 2021

SELL
$3.01 - $3.78 $40,559 - $50,935
-13,475 Reduced 77.03%
4,018 $13,000
Q1 2021

May 17, 2021

BUY
$3.33 - $6.5 $43,679 - $85,260
13,117 Added 299.75%
17,493 $66,000
Q4 2020

Feb 16, 2021

SELL
$2.88 - $4.33 $54,936 - $82,594
-19,075 Reduced 81.34%
4,376 $17,000
Q3 2020

Nov 16, 2020

BUY
$2.94 - $4.05 $65,512 - $90,246
22,283 Added 1907.79%
23,451 $75,000
Q2 2020

Aug 13, 2020

BUY
$2.89 - $4.32 $3,375 - $5,045
1,168 New
1,168 $5,000
Q1 2020

May 15, 2020

SELL
$2.47 - $5.16 $1,462 - $3,054
-592 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$4.28 - $5.95 $560 - $779
-131 Reduced 18.12%
592 $3,000
Q3 2019

Nov 05, 2019

SELL
$2.97 - $6.42 $234 - $507
-79 Reduced 9.85%
723 $4,000
Q2 2019

Aug 13, 2019

BUY
$2.93 - $3.6 $2,349 - $2,887
802 New
802 $3,000
Q1 2019

May 14, 2019

SELL
$2.19 - $3.45 $3,893 - $6,134
-1,778 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.7 - $2.88 $2,738 - $4,639
1,611 Added 964.67%
1,778 $3,000
Q3 2018

Nov 13, 2018

SELL
$1.57 - $2.59 $5,881 - $9,702
-3,746 Reduced 95.73%
167 $0
Q2 2018

Aug 15, 2018

BUY
$1.88 - $2.41 $6,235 - $7,993
3,317 Added 556.54%
3,913 $8,000
Q1 2018

May 15, 2018

BUY
$2.29 - $3.95 $1,364 - $2,354
596 New
596 $1,000
Q4 2017

Feb 09, 2018

SELL
$2.1 - $3.72 $14,347 - $25,415
-6,832 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.45 - $2.98 $16,738 - $20,359
6,832
6,832 $18,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.